We provide you with 20 years of free, institutional-grade data for CBAY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CBAY. Explore the full financial landscape of CBAY stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Dorling Janet | Sale | -6,000 | $31.97 | $191,849 | 2024-02-14 |
| Dorling Janet | Derivatives Exercise | 6,000 | 2024-02-14 | ||
| McWherter Charles | Grant, award...etc | 31,938 | 2024-01-26 | ||
| Quinlan Paul T | Grant, award...etc | 28,438 | 2024-01-26 | ||
| Shah Sujal | Grant, award...etc | 96,250 | 2024-01-26 | ||
| Shantharam Harish | Grant, award...etc | 20,125 | 2024-01-26 | ||
| Dickinson Klara | Grant, award...etc | 21,000 | 2024-01-26 | ||
| McWherter Charles | Sale | -18,403 | $23.67 | $435,638 | 2024-01-22 |
| McWherter Charles | Derivatives Exercise | 18,403 | 2024-01-22 | ||
| Quinlan Paul T | Sale | -5,000 | $23.58 | $117,898 | 2024-01-16 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2024-01-16 | ||
| Menold Daniel | Sale | -10,000 | $23.58 | $235,806 | 2024-01-16 |
| Menold Daniel | Derivatives Exercise | 10,000 | 2024-01-16 | ||
| Dorling Janet | Sale | -6,000 | $23.86 | $143,144 | 2024-01-10 |
| Dorling Janet | Derivatives Exercise | 6,000 | 2024-01-10 | ||
| McWherter Charles | Sale | -11,332 | $21.49 | $243,487 | 2023-12-18 |
| McWherter Charles | Derivatives Exercise | 11,332 | 2023-12-18 | ||
| Quinlan Paul T | Sale | -5,000 | $21.98 | $109,903 | 2023-12-15 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-12-15 | ||
| Menold Daniel | Sale | -21,497 | $21.98 | $472,605 | 2023-12-15 |
| Menold Daniel | Derivatives Exercise | 21,497 | 2023-12-15 | ||
| Dorling Janet | Sale | -6,000 | $20.07 | $120,422 | 2023-12-11 |
| Dorling Janet | Derivatives Exercise | 6,000 | 2023-12-11 | ||
| Shah Sujal | Sale | -64,865 | $19.99 | $1,296,437 | 2023-12-11 |
| Shah Sujal | Derivatives Exercise | 64,865 | 2023-12-11 | ||
| Quinlan Paul T | Sale | -5,000 | $17.38 | $86,889 | 2023-11-17 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-11-17 | ||
| Menold Daniel | Derivatives Exercise | 17,500 | 2023-11-17 | ||
| McWherter Charles | Sale | -11,342 | $18.28 | $207,293 | 2023-11-17 |
| McWherter Charles | Derivatives Exercise | 11,342 | 2023-11-17 | ||
| Shah Sujal | Sale | -64,863 | $15.89 | $1,030,706 | 2023-11-14 |
| Shah Sujal | Derivatives Exercise | 64,863 | 2023-11-14 | ||
| Dorling Janet | Sale | -7,000 | $15.24 | $106,700 | 2023-11-14 |
| Dorling Janet | Derivatives Exercise | 7,000 | 2023-11-14 | ||
| McWherter Charles | Sale | -21,743 | $14.07 | $305,941 | 2023-10-18 |
| McWherter Charles | Derivatives Exercise | 21,743 | 2023-10-18 | ||
| Menold Daniel | Derivatives Exercise | 17,500 | 2023-10-18 | ||
| Quinlan Paul T | Sale | -5,000 | $13.76 | $68,798 | 2023-10-18 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-10-18 | ||
| Shah Sujal | Sale | -64,861 | $14.2 | $921,286 | 2023-10-10 |
| Shah Sujal | Derivatives Exercise | 64,861 | 2023-10-10 | ||
| EMSTER KURT VON | Sale | -15,921 | $15.68 | $249,675 | 2023-09-29 |
| EMSTER KURT VON | Derivatives Exercise | 15,921 | 2023-09-29 | ||
| Quinlan Paul T | Sale | -53,000 | $16.87 | $893,877 | 2023-09-19 |
| Quinlan Paul T | Derivatives Exercise | 53,000 | 2023-09-19 | ||
| McWherter Charles | Sale | -21,746 | $16.22 | $352,733 | 2023-09-19 |
| McWherter Charles | Derivatives Exercise | 21,746 | 2023-09-19 | ||
| Menold Daniel | Derivatives Exercise | 16,545 | 2023-09-19 | ||
| McWherter Charles | Sale | -21,746 | $11.47 | $249,359 | 2023-08-18 |
| McWherter Charles | Derivatives Exercise | 21,746 | 2023-08-18 | ||
| Quinlan Paul T | Sale | -5,000 | $11.91 | $59,551 | 2023-08-16 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-08-16 | ||
| Menold Daniel | Derivatives Exercise | 15,500 | 2023-08-16 | ||
| Menold Daniel | Sale | -20,945 | $12.35 | $258,744 | 2023-08-11 |
| Menold Daniel | Derivatives Exercise | 20,945 | 2023-08-11 | ||
| McWherter Charles | Sale | -21,749 | $11.43 | $248,519 | 2023-07-19 |
| McWherter Charles | Derivatives Exercise | 21,749 | 2023-07-19 | ||
| Quinlan Paul T | Sale | -5,000 | $11.81 | $59,050 | 2023-07-14 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-07-14 | ||
| Quinlan Paul T | Sale | -5,000 | $10.05 | $50,250 | 2023-06-30 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-06-30 | ||
| McWherter Charles | Sale | -21,749 | $8.16 | $177,383 | 2023-06-21 |
| McWherter Charles | Derivatives Exercise | 21,749 | 2023-06-21 | ||
| McWherter Charles | Sale | -21,749 | $9.08 | $197,387 | 2023-05-19 |
| McWherter Charles | Derivatives Exercise | 21,749 | 2023-05-19 | ||
| Quinlan Paul T | Sale | -5,000 | $10.37 | $51,831 | 2023-05-17 |
| Quinlan Paul T | Derivatives Exercise | 5,000 | 2023-05-17 | ||
| KIM DENNIS D | Sale | -120,000 | $8.98 | $1,077,708 | 2023-04-17 |
| KIM DENNIS D | Derivatives Exercise | 120,000 | 2023-04-17 | ||
| KIM DENNIS D | Sale | -100 | $8.98 | $899 | 2023-03-30 |
| KIM DENNIS D | Derivatives Exercise | 100 | 2023-03-30 |
The information provided in this report about CBAY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CymaBay Therapeutics, Inc(NASDAQ:CBAY) 
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has com...
Website: http://www.cymabay.com
Founded: 1988
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology